iKang Healthcare (KANG) Reports Q2 EPS of $0.29
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
iKang Announces Unaudited Financial Results for the Fiscal Second Quarter Ended September 30, 2017
December 14, 2017 5:02 PM ESTBEIJING, Dec. 14, 2017 (GLOBE NEWSWIRE) -- iKang Healthcare Group, Inc. (iKang or the Company) (Nasdaq: KANG), a major provider in Chinas fast growing private preventive healthcare services market, today announced its unaudited financial results for the fiscal second quarter ended September 30, 2017.
Fiscal Second Quarter Ended September 30, 2017 Financial Highlights
Net revenues were US$152.4 million, an increase of 27.3% year-over-year (an increase of 27.4% on RMB basis) (1) Gross profit was US$70.7 million, an increase of 30.6% year-over-year (an increase of 30.7% on RMB basis) (1) Net income attributable to the Company... More